AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Transaction in Own Shares Dec 13, 2024

5328_rns_2024-12-13_49fecb01-210a-46f7-a80e-6c1547fcc051.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9474P

Spire Healthcare Group PLC

13 December 2024

13 December 2024

Spire Healthcare Group plc

Transaction in own shares

Spire Healthcare Group plc (the "Company") announces that, in accordance with the terms of its share buyback programme announced on 31 October 2024 (the "Share Buyback Programme") and the authority granted by its shareholders at the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased the following number of its ordinary shares of 1 pence each ("Shares") on the London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):

Date of purchase: 12 December 2024
Number of Shares purchased: 50,000
Highest price paid per Share (GBp): 225.50
Lowest price paid per Share (GBp): 223.00
Volume weighted average price paid per Share (GBp): 225.1510
Broker: Deutsche Numis
Trading venue: London Stock Exchange

The purchased Shares will be cancelled.

Following the purchase of these Shares, the remaining number of Shares in issue will be 403,049,249. The Company does not hold any Shares in treasury. Therefore, the total number of voting rights in the Company is 403,049,249. This figure may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Deutsche Numis as part of the Share Buyback Programme:

Date of purchase Number of ordinary shares purchased Transaction price

(GBp share)
Time of transaction (UK Time) Transaction reference number Trading venue
12 December 2024 518 223.00 09:27:04 00072803499TRLO0 XLON
12 December 2024 1691 223.00 09:27:04 00072803500TRLO0 XLON
12 December 2024 7999 225.00 14:19:11 00072812038TRLO0 XLON
12 December 2024 2000 225.00 14:19:11 00072812037TRLO0 XLON
12 December 2024 30 225.00 14:19:11 00072812035TRLO0 XLON
12 December 2024 2023 225.00 14:19:11 00072812034TRLO0 XLON
12 December 2024 30 225.00 14:19:11 00072812033TRLO0 XLON
12 December 2024 2179 225.00 14:19:11 00072812032TRLO0 XLON
12 December 2024 1016 225.00 14:19:11 00072812031TRLO0 XLON
12 December 2024 60 225.00 14:19:11 00072812042TRLO0 XLON
12 December 2024 265 225.00 14:19:11 00072812041TRLO0 XLON
12 December 2024 484 225.00 14:19:11 00072812040TRLO0 XLON
12 December 2024 1800 225.00 14:19:11 00072812039TRLO0 XLON
12 December 2024 2141 225.00 14:33:25 00072812831TRLO0 XLON
12 December 2024 425 225.00 14:56:25 00072813783TRLO0 XLON
12 December 2024 2024 225.00 14:56:25 00072813782TRLO0 XLON
12 December 2024 359 225.50 15:29:50 00072815109TRLO0 XLON
12 December 2024 381 225.50 15:29:50 00072815108TRLO0 XLON
12 December 2024 1000 225.50 15:29:50 00072815107TRLO0 XLON
12 December 2024 442 225.50 15:29:50 00072815106TRLO0 XLON
12 December 2024 558 225.50 15:29:50 00072815105TRLO0 XLON
12 December 2024 1000 225.50 15:29:50 00072815104TRLO0 XLON
12 December 2024 289 225.50 15:29:50 00072815103TRLO0 XLON
12 December 2024 504 225.50 15:29:50 00072815102TRLO0 XLON
12 December 2024 2029 225.50 15:29:50 00072815101TRLO0 XLON
12 December 2024 35 225.50 15:29:50 00072815100TRLO0 XLON
12 December 2024 2221 225.50 15:29:50 00072815099TRLO0 XLON
12 December 2024 278 225.50 16:13:39 00072816755TRLO0 XLON
12 December 2024 523 225.50 16:13:39 00072816754TRLO0 XLON
12 December 2024 2385 225.50 16:13:39 00072816753TRLO0 XLON
12 December 2024 1533 225.50 16:13:39 00072816752TRLO0 XLON
12 December 2024 524 225.50 16:13:39 00072816756TRLO0 XLON
12 December 2024 769 225.50 16:13:40 00072816761TRLO0 XLON
12 December 2024 39 225.50 16:13:43 00072816763TRLO0 XLON
12 December 2024 116 225.50 16:15:00 00072816833TRLO0 XLON
12 December 2024 410 225.50 16:16:20 00072816944TRLO0 XLON
12 December 2024 2130 225.50 16:16:20 00072816949TRLO0 XLON
12 December 2024 2001 225.50 16:16:20 00072816948TRLO0 XLON
12 December 2024 2104 225.50 16:16:20 00072816947TRLO0 XLON
12 December 2024 2139 225.50 16:16:20 00072816946TRLO0 XLON
12 December 2024 165 225.50 16:16:20 00072816945TRLO0 XLON
12 December 2024 12 225.00 16:16:21 00072816950TRLO0 XLON
12 December 2024 1369 225.00 16:16:21 00072816951TRLO0 XLON

This announcement will also be available on the Company's website at:

https://investors.spirehealthcare.com/news/regulatory-news/

Enquiries:

Spire Healthcare
Harbant Samra, CFO +44 (0)7881 672 365
Instinctif Partners
Julian Walker +44 (0)7825 189 696

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

About Spire Healthcare

Spire Healthcare is a leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFLLLFZLLEFBQ

Talk to a Data Expert

Have a question? We'll get back to you promptly.